北美病毒学市场预测至 2028 年 - COVID-19 影响和按类型（诊断测试、病毒感染控制技术、抗病毒治疗和干扰素）、应用（皮肤和软组织感染、呼吸道感染、胃肠道感染、性）的区域分析传染病、尿路感染等）和最终用户（医院、诊断实验室、制药和生物技术公司以及研究和学术机构）

市场介绍

北美病毒学市场基于三个主要国家进行分析：美国、加拿大和墨西哥。由于新冠病毒负担增加、产品发布增加等因素，美国拥有最大的病毒学市场规模。在北美，美国是病毒学解决方案的最大市场。美国市场的增长主要得益于研发活动的增加以及对治疗慢性病和病毒性疾病的先进诊断解决方案的需求不断增长。此外，由于先进病毒检测的不断采用，对病毒抗原的需求不断增加，预计也将在预测期内推动市场发展。由于需求不断增加，市场主要参与者都专注于扩大病毒抗原的生产能力。该国的制药和生物技术公司正在积极运作，开发针对新冠病毒的有效疫苗。多个参与者已收到各自疫苗的 EUA。这些数据正在不断进行更大规模的研究，药品制造商也在不断开发针对新冠病毒的抗病毒药物。然而，尽管疫苗已商业化且广泛使用，但主要重点仍然是对新冠病毒进行最大限度的检测以控制感染率。例如，2020 年 5 月，美国 FDA 批准了 Quidel 公司针对 Sofia 2 SARS 抗原 FIA 进行的 COVID19 抗原测试的紧急使用授权。因此，监管机构的类似批准预计将支持病毒学市场的增长。病毒传染病流行率的上升是推动北美病毒学市场增长的主要因素。

自 COVID-19 爆发以来，北美的病例数量不断增加。该地区墨西哥和加拿大等国家的病例也在增加。由于新冠病毒是一种新型病毒，目前还没有既定的治疗方法，也没有针对该病毒的疫苗、药物。因此，对于从事病毒学相关业务的市场参与者来说，这是产品创新和开发的潜在机会。各国政府广泛投资和促进疫苗开发，并优先考虑简单、快速的审批流程。区域和国际参与者推出了各种病毒产品，例如快速检测试剂盒、疫苗等。这些产品的大规模生产和不断增长的需求预计将对该地区的病毒学相关市场产生有利影响。然而，终端用户的抢购和囤货预计将导致产品到期造成损失。因此，预计这些因素将对该地区的相关市场产生负面影响。

市场概况和动态

北美病毒学市场预计将从2021年的15.3121亿美元增长到2028年的19.8433亿美元；预计 2021 年至 2028 年复合年增长率为 3.8%。墨西哥等国家对于该地区的制药和生物制药行业来说是有吸引力的外包地点。墨西哥较低的制造和运营成本以及制药行业的近期增长是推动该国病毒学相关市场增长的关键因素。此外，不断增长的国内市场及其管道正在为该地区的仿制药生产开辟新的途径。此外，一些合同组织正在扩大其在北美国家的制造能力，以满足对疫苗等产品不断增长的需求。因此，新兴市场可能会在未来几年为北美地区病毒学市场的增长创造利润丰厚的机会。

关键细分市场

北美病毒学市场根据类型、应用、最终用户和国家/地区进行细分。根据类型，市场分为诊断测试、病毒感染控制技术、抗病毒治疗和干扰素。抗病毒治疗领域在 2020 年占据市场主导地位，病毒感染控制技术领域预计将在预测期内增长最快。诊断测试部分进一步分为DNA病毒测试、RNA病毒测试等。同样，病毒感染控制技术分为主动预防和被动预防。同样，抗病毒治疗部分分为杀病毒剂、抗病毒剂、免疫调节剂和干扰素。根据应用，病毒学市场分为皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播疾病、尿路感染等。呼吸道感染领域在 2020 年占据市场主导地位，预计将在预测期内增长最快。根据最终用户，病毒学市场分为医院、诊断实验室、制药和生物技术公司以及研究和学术机构。医院细分市场在 2020 年占据市场主导地位，诊断实验室细分市场预计将在预测期内增长最快。

主要来源和上市公司

准备这份北美病毒学市场报告时提到的一些主要的一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培（Abbott）；艾伯维公司； F.霍夫曼-拉罗氏有限公司；吉利德科学公司；葛兰素史克公司；照明公司；强生服务公司；凯杰；西门子公司；和 Thermo Fisher Scientific Inc. 等。

购买报告的理由

了解北美病毒学市场格局并确定最有可能保证强劲回报的细分市场
通过以下方式保持领先地位了解北美病毒学市场不断变化的竞争格局
通过识别最有前景的细分市场，有效规划北美病毒学市场的并购和合作交易
通过对北美病毒学市场各个细分市场的市场表现进行敏锐和全面的分析，有助于做出明智的业务决策
获取北美地区 2021-2028 年各个细分市场的市场收入预测 .

北美病毒学市场细分

北美病毒学市场 - 按类型

诊断测试
DNA病毒测试
RNA病毒测试
其他
病毒感染控制技术
主动预防
被动预防
抗病毒治疗
杀病毒剂
抗病毒剂
免疫调节剂
干扰素

北美病毒学市场 - 按应用

北美病毒学市场 - 按最终用户

医院
诊断实验室
制药和生物技术公司
研究和学术机构

北美病毒学市场 - 按国家/地区

美国
加拿大
墨西哥

北美病毒学市场-公司简介

TABLE OF CONTENTS
1.           Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        North America Virology Market – By Type
1.3.2        North America Virology Market – By Application
1.3.3        North America Virology Market – By End User
1.3.4        North America Virology Market– By Country
2.           North America Virology Market – Key Takeaways
3.           Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           North America Virology Market– Market Landscape
4.1         Overview
4.2         North America PEST Analysis
4.3         Experts Opinion
5.           North America Virology Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Rise in Prevalence of Viral Infectious Diseases
5.1.2        Increasing Product Launches
5.2         Market Restraints
5.2.1        Availability of Alternative Products and High Cost of Production of Products
5.3         Market Opportunities
5.3.1        Tremendous Growth Potential in Several Economies
5.4         Future Trends
5.4.1        Continuous Requirement for Cost-Effective Products
5.5         Impact Analysis
6.           Virology Market– North America Analysis
6.1         North America Virology Market Revenue Forecast and Analysis
7.           North America Virology Market Analysis – By Type
7.1         Overview
7.2         North America Virology Market Revenue Share, by Type (2021 and 2028)
7.3         Diagnostic Test
7.3.1        Overview
7.3.2        Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1          Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1          Overview
7.3.2.1.2          DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2          Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1          Overview
7.3.2.2.2          RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3          Others
7.3.2.3.1          Overview
7.3.2.3.2          Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4         Viral Infection Controlling Techniques
7.4.1        Overview
7.4.2        Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1          Active Prophylaxis
7.4.2.1.1          Overview
7.4.2.1.2          Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2          Passive Prophylaxis
7.4.2.2.1          Overview
7.4.2.2.2          Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5         Antiviral Therapeutics
7.5.1        Overview
7.5.2        Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1          Virucidal Agents
7.5.2.1.1          Overview
7.5.2.1.2          Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2          Antiviral Agents
7.5.2.2.1          Overview
7.5.2.2.2          Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3          Immunomodulators
7.5.2.3.1          Overview
7.5.2.3.2          Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6         Interferons
7.6.1        Overview
7.6.2        Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.           North America Virology Market Analysis – By Application
8.1         Overview
8.2         North America Virology Market, by Application 2021 & 2028 (%)
8.3         Skin and Soft Tissue Infections
8.3.1        Overview
8.3.2        Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4         Respiratory Tract Infections
8.4.1        Overview
8.4.2        Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5         GI Tract Infections
8.5.1        Overview
8.5.2        GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6         Sexually Transmitted Diseases
8.6.1        Overview
8.6.2        Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7         Urinary Tract Infections
8.7.1        Overview
8.7.2        Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8         Others
8.8.1        Overview
8.8.2        Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.           North America Virology Market Analysis – By End User
9.1         Overview
9.2         North America Virology Market Revenue Share, by End User (2021 and 2028)
9.3         Hospitals
9.3.1        Overview
9.3.2        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4         Diagnostic Laboratories
9.4.1        Overview
9.4.2        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5         Pharmaceutical and Biotechnological Companies
9.5.1        Overview
9.5.2        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6         Research and Academic Institutes
9.6.1        Overview
9.6.2        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10.        North America Virology Market – Country Analysis
10.1.1     Overview
10.1.2     North America: Virology Market, by Country, 2021 & 2028 (%)
10.1.2.1       US: Virology Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1       Overview
10.1.2.1.2       US: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3       US: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.1.3.1    US: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.1.3.2    US: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.1.3.3    US: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.1.4       US: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5       US: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.2       Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1       Overview
10.1.2.2.2       Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3       Canada: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.2.3.1    Canada: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.2.3.2    Canada: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.2.3.3    Canada: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.2.4       Canada: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5       Canada: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.3       Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1       Overview
10.1.2.3.2       Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3       Mexico: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.3.3.1    Mexico: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.3.3.2    Mexico: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.3.3.3    Mexico: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.3.4       Mexico: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5       Mexico: Virology Market, by End User, 2019–2028 (USD Million)
11.        Impact of COVID-19 Pandemic on North America Virology Market
11.1      Overview
12.        North America Virology Market–Industry Landscape
12.1      Overview
12.2      Organic Developments
12.2.1     Overview
12.3      Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1      Abbott
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      Johnson and Johnson Services, Inc.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      F. HOFFMANN-LA ROCHE LTD.
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      THERMO FISHER SCIENTIFIC INC.
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      QIAGEN
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Illumina, Inc.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      Siemens AG
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      GlaxoSmithKline Plc
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9      AbbVie Inc.
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
13.10   Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             North America Virology Market Revenue and Forecast to 2028 (US$ Million)
Table 2.             US: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3.             US: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 4.             US: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 5.             US: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 6.             US: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7.             US Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8.             Canada: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9.             Canada: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 10.          Canada: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 11.          Canada: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 12.          Canada: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13.          Canada: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14.          Mexico: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15.          Mexico: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 16.          Mexico: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 17.          Mexico: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 18.          Mexico: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19.          Mexico: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20.          Organic Developments Done by Companies
Table 21.          Inorganic Developments Done by Companies
Table 22.          Glossary of Terms, North America Virology Market

LIST OF FIGURES
Figure 1.           North America Virology Market Segmentation
Figure 2.           North America Virology Segmentation, By Country
Figure 3.           North America Virology Market Overview
Figure 4.           Antiviral Therapeutics Held the Largest Share of the Type Segment in North America Virology Market
Figure 5.           Respiratory Tract Infections Held the Largest Share of the Application Segment in North America Virology Market
Figure 6.           US to Show Significant Growth During Forecast Period
Figure 7.           North America PEST Analysis
Figure 8.           North America Virology Market: Impact Analysis of Drivers and Restraints
Figure 9.           North America Virology Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10.        North America Virology Market Revenue Share, by Type (2021 and 2028)
Figure 11.        North America Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12.        North America DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13.        North America RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14.        North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15.        North America Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16.        North America Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17.        North America Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18.        North America Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19.        North America Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20.        North America Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21.        North America Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22.        North America Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23.        North America Virology Market, by Application 2021 & 2028 (%)
Figure 24.        North America Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        North America Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        North America GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        North America Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28.        North America Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29.        North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30.        North America Virology Market Revenue Share, by End User (2021 and 2028)
Figure 31.        North America Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32.        North America Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33.        North America Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34.        North America Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35.        North America: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 36.        North America: Virology Market, by Country, 2021 & 2028 (%)
Figure 37.        US: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 38.        Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 39.        Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 40.        Impact of COVID-19 Pandemic in North American Country Markets

Abbott
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Illumina, Inc.
Johnson and Johnson Services, Inc.
QIAGEN
Siemens AG
Thermo Fisher Scientific Inc.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Virology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America Virology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022

North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022

North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.